Valuation: SMAIO

Market Cap 36.5M 41.86M 34.46M 31.3M 58.63M 4.02B 58.88M 413M 159M 2.04B 157M 154M 6.57B P/E 2026 *
-16.6x
P/E 2027 * 162x
Enterprise Value 35M 40.14M 33.05M 30.01M 56.22M 3.85B 56.46M 396M 153M 1.96B 151M 147M 6.3B EV / Sales 2026 *
3.18x
EV / Sales 2027 * 2.22x
Free-Float
14.95%
Yield 2026 *
-
Yield 2027 * -
1 day+1.89%
1 week-12.43%
Current month-14.06%
1 month-14.74%
3 months-17.77%
6 months-8.73%
Current year+3.68%
1 week 6.16
Extreme 6.16
7.4
1 month 6.16
Extreme 6.16
7.76
Current year 6
Extreme 6
9.1
1 year 5.9
Extreme 5.9
9.1
3 years 2.25
Extreme 2.25
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 29/12/2008
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2020
Director TitleAgeSince
Chairman - 30/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.89%-12.43%-1.07%+157.14% 41.86M
+0.04%+3.34%+53.32%+102.40% 1,028B
-0.09%+1.66%+53.24%+65.73% 651B
-0.02%+2.66%+18.65%+71.84% 466B
-1.22%+3.66%+34.59%+39.32% 346B
-0.79%+2.73%+17.73%+23.91% 266B
+0.58%+6.76%+10.58%+14.16% 259B
+1.55%+2.20%+35.12%+42.07% 208B
+0.79%+1.84%-27.55%-57.51% 191B
-0.52%+4.45%+31.57%+97.98% 186B
Average +0.22%+1.69%+22.62%+55.70% 360.18B
Weighted average by Cap. -0.04%+3.09%+34.84%+61.41%

Financials

2026 *2027 *
Net sales 11M 12.61M 10.39M 9.43M 17.67M 1.21B 17.75M 124M 48.01M 615M 47.39M 46.33M 1.98B 16M 18.35M 15.11M 13.72M 25.7M 1.76B 25.81M 181M 69.83M 895M 68.93M 67.4M 2.88B
Net income -2.25M -2.58M -2.12M -1.93M -3.61M -248M -3.63M -25.45M -9.82M -126M -9.69M -9.48M -405M 250K 287K 236K 214K 402K 27.51M 403K 2.83M 1.09M 13.99M 1.08M 1.05M 45M
Net Debt -1.5M -1.72M -1.42M -1.29M -2.41M -165M -2.42M -16.97M -6.55M -83.92M -6.46M -6.32M -270M -900K -1.03M -850K -772K -1.45M -99.04M -1.45M -10.18M -3.93M -50.35M -3.88M -3.79M -162M
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
18/09/26 €6.480 +1.89% 1,236
17/09/26 €6.360 -4.50% 1,100
16/09/26 €6.660 -2.92% 825
15/09/26 €6.860 -8.53% 888
14/09/26 €7.500 +1.35% 21
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.480EUR
Average target price
8.200EUR
Spread / Average Target
+26.54%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!